期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
子宫内膜癌组织中端粒蛋白TRF1和TRF2的表达及意义 被引量:1
1
作者 梁春燕 许红雁 +4 位作者 刘志玲 谭丽珊 区美瑜 黄艳萍 钟桦 《中国优生与遗传杂志》 2016年第12期47-50,F0002,共5页
目的研究子宫内膜癌组织内端粒蛋白TRF1、TRF2的表达水平及临床应用意义。方法选取韶关市第一人民医院2015年1月-2016年12月住院部收治的60例子宫内膜癌患者作为病例组,同时选取同期在我院行诊断性刮宫术治疗的30例健康子宫内膜患者作... 目的研究子宫内膜癌组织内端粒蛋白TRF1、TRF2的表达水平及临床应用意义。方法选取韶关市第一人民医院2015年1月-2016年12月住院部收治的60例子宫内膜癌患者作为病例组,同时选取同期在我院行诊断性刮宫术治疗的30例健康子宫内膜患者作为对照组。采用免疫组化方法对两组患者的端粒蛋白TRF1、TRF2及细胞分化水平进行检测,并比较两组患者端粒蛋白TRF1、TRF2阳性率。结果子宫内膜癌的病理分级、临床分期、淋巴结转移、肌层浸润等情况与端粒蛋白TRF1、TRF2的表达水平无明显相关性;TRF1、TRF2在子宫内膜癌、健康子宫内膜内表达相关性明显(Rs_1=0.519,P_1=0.000;Rs_2=0.541,P_2=0.000)。结论临床医学可根据端粒蛋白TRF1、TRF2表达水平进行早期子宫内膜癌防治,为临床医学研究提供分子生物学机制,降低子宫内膜癌发生风险,改善治疗效果。 展开更多
关键词 子宫内膜癌 端粒蛋白trf1 端粒蛋白trf2 阳性率
原文传递
A study of the relationship between expression level of TRF1 protein and telomerase activity in human acute leukemia 被引量:4
2
作者 施继敏 黄河 +1 位作者 陈巧芳 林茂芳 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2006年第2期154-158,共5页
Objective: To study the expression level of TRF1 (telomeric repeat binding factor 1) protein in human acute leukemia and relationship between expression level of TRF1 protein and telomerase, Methods: A quantitativ... Objective: To study the expression level of TRF1 (telomeric repeat binding factor 1) protein in human acute leukemia and relationship between expression level of TRF1 protein and telomerase, Methods: A quantitative Western±Blot technique was developed using anti±TRF1^33±277 monoclonal antibody and GST±TRFI purity protein as a standard to further determine the expression level of TRF1 protein in total proteins extracted from clinical specimens. Results: Bone marrow tissues of 20 acute leukemia patients were studied, 11 healthy donors' bone marrows were taken as a control. The expression level of TRF1 protein was significantly higher (P〈0.01) in normal bone marrow ((2.2174±0.462) μg/μl) than that of acute leukemia patients ((0.7544±0.343) μg/μl), But there was no remarkable difference between ALL and ANLL patients ((0.6184±0.285) μg/μl vs (0.8454±0.359) μg/μl, P〉0.05). After chemotherapy, TRFI expression level of patients with complete remission elevated ((0.7724±0.307)/μg/μl vs (1.6834±0,344)μg/μl, P〈0.01 ), but lower than that of normal ((2.2174±0.462)/μg/μl, P〈0.01). There was no significantly difference after chemotherapy ((0.7264±0.411) μg/μl vs (0.895±0.339) μg/μl,p〉0.05). TRF1 expression level of patients with complete remission is higher than that of patients without complete remission ((1,683±0.344)μg/μl vs (0.895±0.339)μg/μl P〈0.01). All samples were determined for telomerase activity. It was confirmed that the activity of telomerase in normal bone marrow was lower than that of acute leukemia patients ((0.125±0.078) μg/μl vs (0.765±0.284)μg/μl, P〈0.01). There was no significant difference of expression level ofTRF I protein between ALL and ANLL patients ((0.897±0.290) μg/μl vs (0.677±0.268) μg/μl, P〉0.05). After chemotherapy, telomerase activity of patients with complete remission decreased ((0.393±0.125) μg/μl), but was still higher than that of normal ((0.125±0.078) μg/μl, P〈0.01). Conclusion: The expression level of TRF1 protein has correlativity to the activity of telomerase (P〈0.001). 展开更多
关键词 Acute leukemia (AL) Human telomeric repeat binding factor protein 1 trfI) Monoclonal antibody Expression level of trf1 protein Telomerase activity
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部